# Zhifeng Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhifeng-pharmaceutical

- Industry: Biotechnology
- Headquarters: Jinhua, China
- Latest round: Series A (Feb 10, 2026)
- Investors on record: 1

## About

Based in Jinhua, China, and founded in 2025, Zhifeng (Jinhua) Pharmaceutical Technology Co., Ltd., trading as Zhifeng Pharmaceutical, is a biopharmaceutical developer primarily engaged in medical research and experimental development, sales of Class II and Class I medical devices, and the operation of Class III medical devices. In February 2026, Zhifeng Pharmaceutical raised a series A+ funding from new investor Puhua Capital.
The company primarily engages in medical research and experimental development, sales of Class II and Class I medical devices, and the operation of Class III medical devices. Zhifeng Pharmaceuticals is committed to advancing the healthcare industry through cutting-edge technology, providing patients with better treatment options.
The company’s revenue is generated by providing biopharmaceutical products and medical devices.
The company will use the series A+ funding to support Zhifeng Pharmaceuticals' continued innovation and development in the field of biopharmaceutical research and development.

## Funding rounds

- Series A, Feb 10, 2026 — Puhua Capital

## Investors

- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series A